SSB and G-Con Form Global Collaboration

Sartorius Stedim Biotech (SSB) and G-Con Manufacturing are rolling out production platforms for the  biopharmaceutical manufacturing industry. SSB has incorporated its products as unit operations into GCon Manufacturing’s modular, mobile clean-room ‘pods ’for individual stages from preparation, culturing and harvesting to ultrafiltration, membrane chromatography and viral clearance for biopharmaceutical development and manufacturing.

Maik Jornitz, SSB’s Senior Vice President of Marketing for Bioprocess Solutions, said, “The combined product portfolio will fundamentally change the way biopharmaceutical manufacturing processes will be designed and configured.

Our Integrated Solutions unit will implement G-Con’s platform of modular clean-room systems into their designs. In addition, our teams will benefit from G-Con’s engineering and design expertise. Our vision is to create standardised unit operations, implemented into the self-contained G-Con modules. These modules can be used as individual process units or joined to an entire process.”

Barry Holtz, President of G-Con Manufacturing, stated, “Our

common goal is to combine our complementary expertise to develop

revolutionary solutions for the next generation of flexible, single-use

manufacturing concepts. We couldn’t be more excited about having

an agreement with a leader in single-use products like Sartorius

Stedim Biotech.”

Effective since the middle of January, G-Con’s modular containment

units are available through SSB’s Integrated Solutions unit.

Jornitz commented: “We do not want to delay the availability of the

G-Con units and therefore decided to have our Integrated Solutions

unit utilise the containment systems and G-Con’s engineering

capabilities now. The global launch through our sales organisations

will follow.”